Day: October 29, 2024

Wilmington, Delaware, Oct. 29, 2024 (GLOBE NEWSWIRE) —  Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from October 28, 2024 to November 28, 2024, on October 28, 2024, I-Fa Chang, manager of the sponsor of the Company, has deposited into its trust account (the “Trust Account”) an aggregate of $60,000 (the “Monthly Extension Payment”). Pursuant to the Company’s third amended & restated memorandum and articles of association (“Current Charter”), effectively April 23, 2024, the Company may extend on a monthly basis from April 28, 2024 until January 28, 2025 or such an earlier date as may be determined...

SAN CARLOS, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT) (“Oportun”, or the “Company”), a mission-driven financial services company, announced today another important step in its plans to optimize the Company’s capital structure and drive improved profitability. Following an extensive review of a range of alternatives led by the Board of Directors, Oportun has entered into a Credit Agreement to refinance its existing corporate financing facility with a new $235 million Senior Secured Term Loan (“Term Loan”). The refinancing will improve Oportun’s operational and balance sheet flexibility with covenants that reflect the performance improvements made by the Company to date, including the agreement to sell the Company’s credit card portfolio, and reward accretive actions and cash flow generation....

Companies will discuss how Lantern’s AI platform is being leveraged for the identification and development of enrichment biomarkers for Actuate’s lead investigational drug product, elraglusibCHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted by Lantern Pharma on October 30, 2024. Andrew Mazar, Ph.D., Chief Operating Officer of Actuate Therapeutics, and Joseph McDermott, Ph.D, Lantern’s computational biologist will discuss the multi-year research and development collaboration that...

SAN FRANCISCO, Oct. 29, 2024 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, today announced the appointment of John Trinta, former CEO of Deloitte Financial Advisory Services, as a member of the Company’s board of directors (the “Board”) and Audit Committee of the Board. Mr. Trinta brings nearly 40 years of expertise in tax and accounting, paired with a proven track record in driving strategic growth and leading organizations to new heights. “It is with great excitement that I introduce John as the newest member of our Board. Having spent nearly four decades at Deloitte, he brings exceptional expertise in finance, accounting, and tax—critical skills as we navigate today’s complexities and continue to position ourselves as a market leader in the clean energy sector,”...

The collaboration aims to discover and develop molecular glue degrader clinical candidates for priority targets to Biogen. Collaboration leverages Neomorph’s leading molecular glue discovery platform and Biogen’s deep expertise in Alzheimer’s, rare, and immunological diseases.CAMBRIDGE, Mass. and SAN DIEGO, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders for priority targets in Alzheimer’s, rare neurological, and immunological diseases. As part of the collaboration, the companies aim to utilize Neomorph’s proprietary molecular glue discovery platform to accelerate the identification and validation of novel small molecule therapeutic molecular glue degraders. Small molecule protein degraders have...

SYDNEY, Oct. 29, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointments of Natalie Faulkner as a Senior Managing Director and Sam Scerri as a Managing Director in the Forensic and Litigation Consulting segment in Sydney, strengthening the firm’s capabilities in Australia. Ms. Faulkner joins the Risk & Investigations practice with more than 25 years of experience in forensic accounting, with a particular focus on the financial services sector. In her role at FTI Consulting, she will help clients with consumer remediation, fraud and scam prevention and detection, corruption and regulatory matters, accounting anomaly investigations and litigation support. “Our clients around the region are experiencing a highly regulated environment and pressure from government agencies to improve risk and governance...

VANCOUVER, British Columbia, Oct. 29, 2024 (GLOBE NEWSWIRE) — Tactical Resources Corp. (TSXV: RARE) (OTC: USREF) (“Tactical Resources” or the “Company”), a mineral exploration and development company, announced today that it intends to make amendments to agreements with certain consultants of the Company. The Company previously entered into consulting agreements (the “Consulting Agreements”) with certain of its consultants, including its Chief Executive Officer and Chief Financial Officer, which would become effective following the closing of a transaction that results in the Company being listed on the New York Stock Exchange or the Nasdaq Stock Market (a “Listing Transaction”). The Company’s previously announced business combination (the “Business Combination”) with Plum Acquisition Corp. III (“Plum”) is expected to constitute...

eGain AI Agent™ delivers breakthrough self-service experience with guided reasoning across knowledge base, website, and enterprise content CHICAGO, Oct. 29, 2024 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the AI knowledge platform for service, announced major product enhancements at its Solve 24 conference in Chicago. By 2025, 100% of generative AI virtual customer assistant and virtual agent assistant projects that lack integration to modern knowledge management systems will fail to meet their customer experience and operational cost-reduction goals, per Gartner. eGain AI Agent™ conversationally engages customers, clarifies intent, guides them to the personalized answer, and explains its approach – inspiring trust and customer adoption. It combines language models and case-based reasoning that tap into trusted...